Oncolytic Virus Cancer Therapy Pipeline Analysis, 2024 - Showing Promise with Over 120 Companies and 125 Drugs in Development [Yahoo! Finance]
Candel Therapeutics, Inc. (CADL)
Company Research
Source: Yahoo! Finance
The field of oncolytic virus cancer therapy continues to show significant promise with more than 120 companies actively pursuing over 125 pipeline drugs. Several products are advancing through the clinical development stages, with notable achievements in securing designations that could expedite their path to market. A variety of oncolytic viruses are under investigation, each with unique mechanisms of action aimed at mobilizing the immune system against cancerous cells. Drugs in the most advanced stage of development hold potential for combating various types of cancer, underscoring the breadth of this therapeutic approach. Collaborations Fueling Innovation Collaborations between industry players and academic institutions are key drivers of innovation in this space. The shared expertise and resources are vital in overcoming challenges and capitalizing on opportunities to refine and enhance the efficacy of oncolytic virus cancer therapies. Focus on Novel Cancer Treatments T
Show less
Read more
Impact Snapshot
Event Time:
CADL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CADL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CADL alerts
High impacting Candel Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CADL
News
- Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference [Yahoo! Finance]Yahoo! Finance
- Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual ConferenceGlobeNewswire
- Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments [Yahoo! Finance]Yahoo! Finance
- Candel Therapeutics to Join Russell 3000® Index [Yahoo! Finance]Yahoo! Finance
- Candel Therapeutics to Join Russell 3000® IndexGlobeNewswire
CADL
Earnings
- 11/9/23 - Miss
CADL
Sec Filings
- 5/30/24 - Form ARS
- 5/30/24 - Form DEF
- 5/30/24 - Form 8-K
- CADL's page on the SEC website